In the MD group, use of benzodiazepine/anticonvulsant ATOD was associated with significantly lower levels of SST mRNA (p = 0.009) (−0.77; [−1.42, −0.11]), although these levels were lower in MD individuals with or without this factor relative to the UC group (Fig. 4D). The gene discussed is SST; the disease is Menkes disease.